During the past decade, Delaware HIV Consortium conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Delaware HIV Consortium" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Delaware HIV Consortium" are "Substance Use" (2 trials). Many other conditions were trialed in "Delaware HIV Consortium" in a lesser frequency.

Most popular intervention types in "Delaware HIV Consortium" are "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "ATTC strategy" (1 trials), "ISF strategy" (1 trials) and "Motivational Interviewing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Delaware HIV Consortium" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Delaware HIV Consortium". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Delaware HIV Consortium, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Delaware HIV Consortium, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".